【4579】ラクオリア創薬

創薬。

類似企業：

【業界1位】武田薬品工業

【売上同水準】室町ケミカル Heartseed

東証グロース

医薬品医薬

＞

新薬メーカー新薬

売上高

営業利益

経常利益

当期利益

業績予想修正

対前回修正率

当初予想比較

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2025.12	2025/02/14	当初予	3,888	-	-	-	118	-	-	-	73	-	-	-	-71	-	-	-
2024.12	2025/02/14	実	3,107	↓	-0.9%	-31.5%	-213	↑	+9.0%	-168.1%	-361	↑	+24.2%	-224.5%	-495	↑	+15.2%	-309.7%
2024.12	2024/12/13	修正予	3,135	↓	-30.9%	-30.9%	-234	↓	-174.8%	-174.8%	-476	↓	-264.1%	-264.1%	-584	↓	-347.5%	-347.5%
2024.12	2024/11/14	Q3予	4,535	→	0.0%	0.0%	313	→	0.0%	0.0%	290	→	0.0%	0.0%	236	→	0.0%	0.0%
2024.12	2024/08/14	Q2予	4,535	→	0.0%	0.0%	313	→	0.0%	0.0%	290	→	0.0%	0.0%	236	→	0.0%	0.0%
2024.12	2024/05/15	Q1予	4,535	→	0.0%	0.0%	313	→	0.0%	0.0%	290	→	0.0%	0.0%	236	→	0.0%	0.0%
2024.12	2024/02/14	当初予	4,535	-	-	-	313	-	-	-	290	-	-	-	236	-	-	-
2023.12	2024/02/14	実	1,901	↓	-1.9%	-32.1%	-337	↑	+17.6%	-229.6%	-293	↑	+13.8%	-221.1%	-323	↑	+24.2%	-276.5%
2023.12	2023/12/08	修正予	1,938	↓	-30.8%	-30.8%	-409	↓	-257.3%	-257.3%	-340	↓	-240.5%	-240.5%	-426	↓	-332.8%	-332.8%
2023.12	2023/11/10	Q3予	2,799	→	0.0%	0.0%	260	→	0.0%	0.0%	242	→	0.0%	0.0%	183	→	0.0%	0.0%
2023.12	2023/08/10	Q2予	2,799	→	0.0%	0.0%	260	→	0.0%	0.0%	242	→	0.0%	0.0%	183	→	0.0%	0.0%
2023.12	2023/05/15	Q1予	2,799	→	0.0%	0.0%	260	→	0.0%	0.0%	242	→	0.0%	0.0%	183	→	0.0%	0.0%
2023.12	2023/02/14	当初予	2,799	-	-	-	260	-	-	-	242	-	-	-	183	-	-	-
2022.12	2023/02/14	実	2,918	↓	-5.1%	+12.0%	866	↑	+5.1%	+106.2%	904	↓	-0.6%	+115.2%	723	↓	-0.1%	+111.4%
2022.12	2022/11/17	修正予	3,075	↑	+18.0%	+18.0%	824	↑	+96.2%	+96.2%	909	↑	+116.4%	+116.4%	724	↑	+111.7%	+111.7%
2022.12	2022/11/11	Q3予	2,605	→	0.0%	0.0%	420	→	0.0%	0.0%	420	→	0.0%	0.0%	342	→	0.0%	0.0%
2022.12	2022/08/15	Q2予	2,605	→	0.0%	0.0%	420	→	0.0%	0.0%	420	→	0.0%	0.0%	342	→	0.0%	0.0%
2022.12	2022/05/13	Q1予	2,605	→	0.0%	0.0%	420	→	0.0%	0.0%	420	→	0.0%	0.0%	342	→	0.0%	0.0%
2022.12	2022/02/14	当初予	2,605	-	-	-	420	-	-	-	420	-	-	-	342	-	-	-
2021.12	2022/02/14	実	2,776	↓	-0.8%	+1.4%	707	↑	+1059.0%	+68.3%	863	↑	+1.8%	+102.1%	755	↑	+0.7%	+120.1%
2021.12	2021/12/20	修正予	2,798	↑	+24.6%	+2.2%	-	-	-	-	848	↑	+360.9%	+98.6%	750	↑	+535.6%	+118.7%
2021.12	2021/11/12	Q3予	2,246	→	0.0%	-18.0%	61	→	0.0%	-85.5%	184	→	0.0%	-56.9%	118	→	0.0%	-65.6%
2021.12	2021/08/12	Q2予	2,246	→	0.0%	-18.0%	61	↓	-85.5%	-85.5%	184	→	0.0%	-56.9%	118	→	0.0%	-65.6%
2021.12	2021/06/30	修正予	2,246	↓	-18.0%	-18.0%	-	-	-	-	184	↓	-56.9%	-56.9%	118	↓	-65.6%	-65.6%
2021.12	2021/05/14	Q1予	2,738	→	0.0%	0.0%	420	→	0.0%	0.0%	427	→	0.0%	0.0%	343	→	0.0%	0.0%
2021.12	2021/02/12	当初予	2,738	-	-	-	420	-	-	-	427	-	-	-	343	-	-	-
2020.12	2021/02/12	実	1,107	→	0.0%	-48.0%	-486	→	0.0%	-794.3%	-527	→	0.0%	-720.0%	-606	→	0.0%	-4761.5%
2020.12	2021/02/02	修正予	1,107	↑	+29.9%	-48.0%	-486	↑	+35.5%	-794.3%	-527	↑	+30.6%	-720.0%	-606	↑	+28.1%	-4761.5%
2020.12	2020/12/28	修正予	852	↓	-46.0%	-60.0%	-753	↓	-189.6%	-1175.7%	-759	↓	-196.5%	-992.9%	-843	↓	-153.2%	-6584.6%
2020.12	2020/11/13	Q3予	1,579	→	0.0%	-25.8%	-260	→	0.0%	-471.4%	-256	→	0.0%	-401.2%	-333	→	0.0%	-2661.5%
2020.12	2020/08/14	Q2予	1,579	↓	-25.8%	-25.8%	-260	↓	-471.4%	-471.4%	-256	↓	-401.2%	-401.2%	-333	↓	-2661.5%	-2661.5%
2020.12	2020/05/15	Q1予	2,129	→	0.0%	0.0%	70	→	0.0%	0.0%	85	→	0.0%	0.0%	13	→	0.0%	0.0%
2020.12	2020/02/14	当初予	2,129	-	-	-	70	-	-	-	85	-	-	-	13	-	-	-
2019.12	2020/02/14	実	1,702	→	0.0%	-15.8%	-15	→	0.0%	-108.0%	21	→	0.0%	-89.2%	5	→	0.0%	-96.7%
2019.12	2020/02/12	修正予	1,702	↓	-3.1%	-15.8%	-15	↑	+82.1%	-108.0%	21	↑	+125.6%	-89.2%	5	↑	+104.7%	-96.7%
2019.12	2019/11/08	Q3予	1,756	→	0.0%	-13.2%	-84	→	0.0%	-144.9%	-82	→	0.0%	-142.1%	-106	→	0.0%	-169.3%
2019.12	2019/09/06	修正予	1,756	↓	-13.2%	-13.2%	-84	↓	-144.9%	-144.9%	-82	↓	-142.1%	-142.1%	-106	↓	-169.3%	-169.3%
2019.12	2019/08/09	Q2予	2,022	→	0.0%	0.0%	187	→	0.0%	0.0%	195	→	0.0%	0.0%	153	→	0.0%	0.0%
2019.12	2019/05/14	Q1予	2,022	→	0.0%	0.0%	187	→	0.0%	0.0%	195	→	0.0%	0.0%	153	→	0.0%	0.0%
2019.12	2019/02/08	当初予	2,022	-	-	-	187	-	-	-	195	-	-	-	153	-	-	-
2018.12	2019/02/08	実	744	↑	+0.8%	-46.4%	-1,075	↓	-7.4%	-54.0%	-1,064	↓	-7.4%	-56.5%	-1,104	↓	-7.3%	-60.9%
2018.12	2019/02/07	修正予	738	↓	-0.7%	-46.8%	-1,001	↑	+14.7%	-43.4%	-991	↑	+14.0%	-45.7%	-1,029	↑	+13.8%	-50.0%
2018.12	2018/12/27	修正予	743	↓	-27.7%	-46.5%	-1,174	↓	-15.3%	-68.2%	-1,152	↓	-15.7%	-69.4%	-1,194	↓	-16.6%	-74.1%
2018.12	2018/11/09	Q3予	1,028	→	0.0%	-25.9%	-1,018	→	0.0%	-45.8%	-996	→	0.0%	-46.5%	-1,024	→	0.0%	-49.3%
2018.12	2018/10/12	修正予	1,028	↓	-25.9%	-25.9%	-1,018	↓	-45.8%	-45.8%	-996	↓	-46.5%	-46.5%	-1,024	↓	-49.3%	-49.3%
2018.12	2018/08/10	Q2予	1,388	→	0.0%	0.0%	-698	→	0.0%	0.0%	-680	→	0.0%	0.0%	-686	→	0.0%	0.0%
2018.12	2018/05/11	Q1予	1,388	→	0.0%	0.0%	-	-	-	-	-680	→	0.0%	0.0%	-686	→	0.0%	0.0%
2018.12	2018/02/09	当初予	1,388	-	-	-	-698	-	-	-	-680	-	-	-	-686	-	-	-
2017.12	2018/02/09	実	1,419	→	0.0%	+29.0%	-150	→	0.0%	+80.3%	-80	→	0.0%	+89.5%	-58	→	0.0%	+92.4%
2017.12	2018/02/06	修正予	1,419	↑	+8.9%	+29.0%	-150	↑	+49.7%	+80.3%	-80	↑	+76.0%	+89.5%	-58	↑	+82.4%	+92.4%
2017.12	2017/12/25	修正予	1,303	↑	+10.8%	+18.5%	-298	↑	+62.3%	+60.8%	-333	↑	+57.1%	+56.2%	-329	↑	+57.7%	+57.1%
2017.12	2017/11/10	Q3予	1,176	→	0.0%	+6.9%	-791	→	0.0%	-4.1%	-777	→	0.0%	-2.1%	-778	→	0.0%	-1.4%
2017.12	2017/08/10	Q2予	1,176	→	0.0%	+6.9%	-791	→	0.0%	-4.1%	-777	→	0.0%	-2.1%	-778	→	0.0%	-1.4%
2017.12	2017/05/12	Q1予	1,176	→	0.0%	+6.9%	-791	→	0.0%	-4.1%	-777	→	0.0%	-2.1%	-778	→	0.0%	-1.4%
2017.12	2017/05/11	修正予	1,176	→	0.0%	+6.9%	-791	→	0.0%	-4.1%	-777	↑	+2.8%	-2.1%	-778	↑	+2.7%	-1.4%
2017.12	2017/04/14	修正予	1,176	↑	+6.9%	+6.9%	-791	↓	-4.1%	-4.1%	-799	↓	-4.0%	-5.0%	-800	↓	-4.0%	-4.3%
2017.12	2017/04/13	修正予	1,100	→	0.0%	0.0%	-760	→	0.0%	0.0%	-768	↓	-0.9%	-0.9%	-769	↓	-0.3%	-0.3%
2017.12	2017/02/10	当初予	1,100	-	-	-	-760	-	-	-	-761	-	-	-	-767	-	-	-
2016.12	2017/02/10	実	705	→	0.0%	-25.8%	-759	↑	+7.0%	+7.3%	-720	↑	+18.3%	+12.1%	-728	↑	+18.0%	+11.8%
2016.12	2017/01/05	修正予	705	↑	+6.8%	-25.8%	-816	↑	+3.4%	+0.4%	-881	↑	+3.2%	-7.6%	-888	↑	+3.2%	-7.6%
2016.12	2016/11/04	修正予	660	↓	-30.5%	-30.5%	-845	↓	-3.2%	-3.2%	-910	↓	-10.6%	-11.1%	-917	↓	-10.2%	-11.2%
2016.12	2016/08/10	Q2予	950	→	0.0%	0.0%	-819	→	0.0%	0.0%	-823	↓	-0.5%	-0.5%	-832	↓	-3.4%	-0.8%
2016.12	2016/05/12	Q1予	950	→	0.0%	0.0%	-819	→	0.0%	0.0%	-819	↓	-2.5%	0.0%	-805	→	0.0%	+2.4%
2016.12	2016/04/28	修正予	950	→	0.0%	0.0%	-819	→	0.0%	0.0%	-799	↑	+2.4%	+2.4%	-805	↑	+2.4%	+2.4%
2016.12	2016/02/12	当初予	950	-	-	-	-819	-	-	-	-819	-	-	-	-825	-	-	-
2015.12	2016/02/12	実	145	↓	-0.7%	-75.8%	-1,864	↑	+2.4%	-26.9%	-1,795	↑	+2.3%	-26.9%	-1,854	↑	+2.1%	-11.6%
2015.12	2015/12/24	修正予	146	→	0.0%	-75.7%	-1,910	→	0.0%	-30.0%	-1,838	→	0.0%	-29.9%	-1,893	↓	-1.5%	-14.0%
2015.12	2015/12/22	修正予	146	↑	+15.9%	-75.7%	-1,910	↑	+1.0%	-30.0%	-1,838	↑	+1.1%	-29.9%	-1,865	↑	+1.7%	-12.3%
2015.12	2015/11/30	修正予	126	→	0.0%	-79.0%	-1,930	→	0.0%	-31.4%	-1,858	→	0.0%	-31.3%	-1,898	↑	+0.5%	-14.3%
2015.12	2015/11/12	修正予	126	↓	-79.0%	-79.0%	-1,930	↓	-34.0%	-31.4%	-1,858	↓	-34.8%	-31.3%	-1,908	↓	-29.4%	-14.9%
2015.12	2015/08/10	Q2予	600	→	0.0%	0.0%	-1,440	→	0.0%	+2.0%	-1,378	→	0.0%	+2.6%	-1,475	→	0.0%	+11.2%
2015.12	2015/07/10	修正予	600	→	0.0%	0.0%	-1,440	↑	+2.0%	+2.0%	-1,378	↑	+4.0%	+2.6%	-1,475	↑	+1.3%	+11.2%
2015.12	2015/05/14	修正予	600	→	0.0%	0.0%	-1,469	-	-	-	-1,435	↓	-1.4%	-1.4%	-1,495	↑	+10.0%	+10.0%
2015.12	2015/02/13	当初予	600	-	-	-	-	-	-	-	-1,415	-	-	-	-1,661	-	-	-
2014.12	2015/02/13	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2014.12	2014/12/16	修正予	153	↓	-49.0%	-49.0%	-2,129	↓	-7.4%	-26.4%	-1,979	↓	-8.0%	-17.5%	-405	↓	-56.4%	-43.6%
2014.12	2014/12/12	修正予	300	→	0.0%	0.0%	-1,983	↓	-17.8%	-17.8%	-1,833	↓	-8.8%	-8.8%	-259	↑	+8.2%	+8.2%
2014.12	2014/11/13	Q3予	300	→	0.0%	0.0%	-1,684	→	0.0%	0.0%	-1,685	→	0.0%	-0.1%	-282	→	0.0%	0.0%
2014.12	2014/08/07	Q2予	300	→	0.0%	0.0%	-1,684	→	0.0%	0.0%	-1,685	↓	-0.1%	-0.1%	-282	→	0.0%	0.0%
2014.12	2014/05/13	Q1予	300	→	0.0%	0.0%	-1,684	→	0.0%	0.0%	-1,684	→	0.0%	0.0%	-282	→	0.0%	0.0%
2014.12	2014/02/14	当初予	300	-	-	-	-1,684	-	-	-	-1,684	-	-	-	-282	-	-	-
2013.12	2014/02/14	実	228	-	-	-	-2,137	-	-	-	-1,819	-	-	-	-1,108	-	-	-

【4579】ラクオリア創薬 創薬。 類似企業： 【業界1位】 武田薬品工業 【売上同水準】 室町ケミカル Heartseed

【4579】ラクオリア創薬

創薬。

類似企業：

【業界1位】武田薬品工業

【売上同水準】室町ケミカル Heartseed